Si-Bone Inc (SIBN) Stock Price, Quote & News

Company Profile

SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with a prop...

Industry: Medical Devices

Sector: Healthcare

Phone: 408 207 0700

Fax: 408 557 8312

Website: si-bone.com

Address:

471 El Camino Real, Suite 101, Santa Clara, United States

d_risk Feb. 24 at 10:03 PM

$SIBN - SI-BONE Inc - 10K - Updated Risk Factors SIBN flags escalating competitive threats (more sacroiliac fusion rivals, named heavyweight device makers, pricing pressure and potential tech lockouts), plus heightened reimbursement risk tied to new CPT code definitions, shifting CMS/ACA policies, and EU HTA rules that could squeeze coverage, pricing, and adoption. #MedicalDevices #CompetitiveThreats #ReimbursementRisk #HealthcarePolicy #PricingPressure 🟢 Added 🟠 Removed https://d-risk.ai/SIBN/10-K/2026-02-24

0 · Reply

WarrenDouglasTrader Feb. 24 at 6:50 PM

$SIBN Crushed earnings and dropped. Makes perfect sense

0 · Reply

erevnon Feb. 24 at 5:27 PM

Truist Securities reiterates SI-BONE $SIBN at Buy and raises the price target from $23 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

topstockalerts Feb. 23 at 11:28 PM

After Hours Top Gainers PT2 $QSEA $BHAT $NWGL $SIBN $ONCO

0 · Reply

Easymoney48 Feb. 23 at 11:21 PM

$SIBN nice! Have to go through the report later. Love high margin businesses.

0 · Reply

player5157 Feb. 23 at 10:46 PM

$SIBN squeeze those shorts like a bad zit.

0 · Reply

StocktwitsEarnings Feb. 23 at 9:19 PM

$SIBN Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.04 up 63.64% YoY • Reported revenue of $56.35M up 15.00% YoY • SI-BONE projects 2026 worldwide revenue between $228.5M and $232.5M, implying 14% to 16% year-over-year growth, with gross margin around 78% and operating expenses growth of ~12.5%.

0 · Reply

Easymoney48 Feb. 23 at 7:13 PM

$SIBN bought a small amount will start building a position.

0 · Reply

BillionerOfKing Feb. 20 at 3:56 AM

$SIBN Current Stock Price: $15.46 Contracts to trade: $17.5 SIBN Feb 20 2026 Call Entry: $0.54 Exit: $0.74 ROI: 38% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

player5157 Feb. 18 at 5:29 PM

$SIBN some days I just don't get the stock market. They're still ten top rated firms calling this a strong buy estimates 2700.-32.00. People just don't like speculation.

1 · Reply

SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call Transcript

Feb 23, 2026, 4:09 PM EST - 2 days ago

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance

Feb 17, 2026, 4:30 PM EST - 8 days ago

SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026

Feb 2, 2026, 4:30 PM EST - 23 days ago

SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026

Jan 12, 2026, 9:00 AM EST - 6 weeks ago

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

Nov 18, 2025, 4:09 PM EST - 3 months ago

SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025

Nov 10, 2025, 8:11 PM EST - 3 months ago

SI-BONE, Inc. (SIBN) Q3 2025 Earnings Call Transcript

Nov 10, 2025, 4:09 PM EST - 3 months ago

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

Oct 28, 2025, 4:26 PM EDT - 4 months ago

Impax Small Cap Fund Q3 2025 Contributors And Detractors

AAMI CIEN HCAT INSP LGND

Oct 20, 2025, 4:09 PM EDT - 4 months ago

SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025

Sep 9, 2025, 11:51 AM EDT - 6 months ago

SI-BONE, Inc. (SIBN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Aug 26, 2025, 4:03 PM EDT - 6 months ago

SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025

Aug 5, 2025, 1:50 AM EDT - 7 months ago

SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 4:09 PM EDT - 7 months ago

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance

Jul 29, 2025, 4:30 PM EDT - 7 months ago

SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025

Jul 14, 2025, 4:09 PM EDT - 8 months ago

SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025

Jun 4, 2025, 4:30 PM EDT - 9 months ago

SI-BONE to Truist Securities MedTech Conference on June 17, 2025

Jun 4, 2025, 4:30 PM EDT - 9 months ago

SI-BONE to Present at Truist Securities MedTech Conference on June 17, 2025

May 28, 2025, 4:30 PM EDT - 9 months ago

SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025

May 6, 2025, 4:09 PM EDT - 10 months ago

SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025

May 5, 2025, 10:38 PM EDT - 10 months ago

SI-BONE, Inc. (SIBN) Q1 2025 Earnings Call Transcript

May 5, 2025, 4:09 PM EDT - 10 months ago

SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance

Feb 24, 2025, 10:29 PM EST - 1 year ago

SI-BONE, Inc. (SIBN) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 4:09 PM EST - 1 year ago

SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance

Feb 21, 2025, 8:00 AM EST - 1 year ago

Bruker Appoints Laura Francis to its Board of Directors

BRKR

Feb 3, 2025, 4:09 PM EST - 1 year ago

SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025

Nov 20, 2024, 4:09 PM EST - 1 year ago

SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024

Nov 12, 2024, 10:42 PM EST - 1 year ago

SI-BONE, Inc. (SIBN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:09 PM EST - 1 year ago

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

Nov 5, 2024, 8:30 AM EST - 1 year ago

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™

Oct 22, 2024, 4:09 PM EDT - 1 year ago

SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

Oct 10, 2024, 8:30 AM EDT - 1 year ago

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation

Aug 22, 2024, 4:30 PM EDT - 1 year ago

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

Aug 20, 2024, 8:30 AM EDT - 1 year ago

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

Aug 6, 2024, 8:30 AM EDT - 1 year ago

SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024

Aug 5, 2024, 11:23 PM EDT - 1 year ago

SI-BONE, Inc. (SIBN) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 4:09 PM EDT - 1 year ago

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024

Jul 15, 2024, 4:09 PM EDT - 1 year ago

SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024

Jun 5, 2024, 4:09 PM EDT - 1 year ago

SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024

May 7, 2024, 9:00 AM EDT - 1 year ago

SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures

May 6, 2024, 8:47 PM EDT - 1 year ago

SI-BONE, Inc. (SIBN) Q1 2024 Earnings Call Transcript

May 6, 2024, 4:09 PM EDT - 1 year ago

SI-BONE, Inc. Reports Financial Results for the First Quarter 2024

Apr 29, 2024, 9:00 AM EDT - 1 year ago

SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

Apr 15, 2024, 4:09 PM EDT - 2 years ago

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024

Mar 4, 2024, 4:09 PM EST - 2 years ago

SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024

Feb 26, 2024, 4:09 PM EST - 2 years ago

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance

Feb 5, 2024, 4:09 PM EST - 2 years ago

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

Jan 30, 2024, 8:30 AM EST - 2 years ago

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

Jan 8, 2024, 8:30 AM EST - 2 years ago

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

d_risk Feb. 24 at 10:03 PM

0 · Reply

WarrenDouglasTrader Feb. 24 at 6:50 PM

$SIBN Crushed earnings and dropped. Makes perfect sense

0 · Reply

erevnon Feb. 24 at 5:27 PM

Truist Securities reiterates SI-BONE $SIBN at Buy and raises the price target from $23 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

topstockalerts Feb. 23 at 11:28 PM

After Hours Top Gainers PT2 $QSEA $BHAT $NWGL $SIBN $ONCO

0 · Reply

Easymoney48 Feb. 23 at 11:21 PM

$SIBN nice! Have to go through the report later. Love high margin businesses.

0 · Reply

player5157 Feb. 23 at 10:46 PM

$SIBN squeeze those shorts like a bad zit.

0 · Reply

StocktwitsEarnings Feb. 23 at 9:19 PM

0 · Reply

Easymoney48 Feb. 23 at 7:13 PM

$SIBN bought a small amount will start building a position.

0 · Reply

BillionerOfKing Feb. 20 at 3:56 AM

0 · Reply

player5157 Feb. 18 at 5:29 PM

$SIBN some days I just don't get the stock market. They're still ten top rated firms calling this a strong buy estimates 2700.-32.00. People just don't like speculation.

1 · Reply

player5157 Feb. 18 at 5:14 PM

$SIBN hoping for a reall green day!? Can't stop the manipulation of the shorts. Hoping for a p r. On or around 24th.

0 · Reply

InvestmentTake Feb. 18 at 4:16 PM

$SIBN SI-BONE operates in minimally invasive orthopedic devices. Revenue growth depends on surgeon adoption and procedure volume. Gross margin expansion supports long-term valuation.

0 · Reply

OfficialStocktwitsUser Feb. 17 at 11:45 AM

$SIBN RSI: 15.06, MACD: -0.8672 Vol: 0.73, MA20: 16.24, MA50: 18.20 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

StrategySuccessor Feb. 4 at 3:44 PM

$SIBN is a medical device company (SI-BONE) focused on minimally invasive surgery for the sacroiliac joint; its growth depends on surgeon education and adoption in a niche market.

0 · Reply

OfficialStocktwitsUser Feb. 3 at 2:22 PM

$SIBN RSI: 21.59, MACD: -0.7337 Vol: 1.65, MA20: 17.94, MA50: 18.87 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

player5157 Jan. 29 at 9:17 PM

$SIBN thank you for the average down day traders , shorts. They tested a new low today. They will be back at it tomorrow. Don't panic sell. Do your own d d on it. Even the big companies are getting good results and they're going down on price.

0 · Reply

player5157 Jan. 29 at 5:48 PM

$SIBN average down?

0 · Reply

erevnon Jan. 27 at 3:20 PM

TD Cowen initiates coverage on SI-BONE $SIBN at Buy rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

player5157 Jan. 13 at 6:06 PM

$SIBN looks like a good time to enter.

0 · Reply

zerodayrounder Jan. 12 at 8:10 PM

$SIBN oops. yank

0 · Reply

cb1961 Jan. 12 at 5:51 PM

$SIBN anyone know why this tanked today?

1 · Reply

BullTrader81 Jan. 7 at 2:46 PM

$SIBN Added

0 · Reply

Market Cap	663.45M
Revenue (ttm)	167.18M
Net Income (ttm)	-30.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-18.49%
Debt to Equity Ratio	0.21

Volume	921,200
Avg Vol	534,392
Day's Range	N/A - N/A
Shares Out	43.39M
Stochastic %K	44%
Beta	0.69
Analysts	Strong Sell
Price Target	$25.50